| Year |
Citation |
Score |
| 2023 |
Ben-Jonathan N, Borcherding DC, Hugo ER. Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews in Oncogenesis. 27: 51-71. PMID 36734872 DOI: 10.1615/CritRevOncog.2022043641 |
0.596 |
|
| 2021 |
Borcherding DC, Hugo ER, Fox SR, Jacobson EM, Hunt BG, Merino EJ, Ben-Jonathan N. Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor. Cancers. 13. PMID 34071395 DOI: 10.3390/cancers13112662 |
0.586 |
|
| 2019 |
Ben-Jonathan N, Borcherding DC, Fox S, Hugo ER. Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1. Cancer Drug Resistance (Alhambra, Calif.). 2: 933-947. PMID 35582277 DOI: 10.20517/cdr.2019.83 |
0.588 |
|
| 2015 |
Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. PMID 26477316 DOI: 10.1038/Onc.2015.369 |
0.609 |
|
| 2011 |
Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, Loftus J, Ben-Jonathan N. Dopamine receptors in human adipocytes: expression and functions. Plos One. 6: e25537. PMID 21966540 DOI: 10.1371/Journal.Pone.0025537 |
0.555 |
|
| 2011 |
Jacobson EM, Hugo ER, Borcherding DC, Ben-Jonathan N. Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discovery Medicine. 11: 315-24. PMID 21524385 |
0.547 |
|
| 2008 |
Hugo ER, Borcherding DC, Gersin KS, Loftus J, Ben-Jonathan N. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. The Journal of Clinical Endocrinology and Metabolism. 93: 4006-12. PMID 18647802 DOI: 10.1210/Jc.2008-1172 |
0.515 |
|
| Show low-probability matches. |